AC

Acadia Healthcare Company IncNASDAQ ACHC Stock Report

Last reporting period 30 Sep, 2024

Updated 18 Dec, 2024

Last price

Market cap $B

7.115

Middle

Exchange

XNAS - Nasdaq

ACHC Stock Analysis

AC

Avoid

Based on Eyestock quantitative analysis, ACHC`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

14/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

95.4 %

Greatly undervalued

Market cap $B

7.115

Dividend yield

Shares outstanding

91.315 B

Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services. The company is headquartered in Franklin, Tennessee and currently employs 17,000 full-time employees. The company went IPO on 2011-11-01. The company is focused on acquiring and developing behavioral healthcare facilities. The company is engaged in developing and operating inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States and Puerto Rico. Its facilities that offer acute care services provide evaluation and crisis stabilization of patients with severe psychiatric diagnoses through a medical delivery model that incorporates structured and intensive medical and behavioral therapies with 24-hour monitoring by a psychiatrist, psychiatric trained nurses, therapists and direct care staff. Its specialty treatment facilities include residential recovery facilities, eating disorder facilities and comprehensive treatment centers.

View Section: Eyestock Rating